Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma

This study has been completed.
Information provided by (Responsible Party):
Dendreon Identifier:
First received: May 4, 2011
Last updated: April 21, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)